DVI-004
Metabolic Disease
PreclinicalRecently disclosed
Key Facts
About Divamics
AI-driven drug discovery company using molecular dynamics and AI to design novel therapeutics for autoimmune and metabolic diseases.
View full company profileTherapeutic Areas
Other Metabolic Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Peptide Programs | AmideBio | Preclinical |
| Undisclosed | Junevity | Pre-clinical |
| Stabilized Peptide Therapeutics (e.g., GLP-1) | Constructive Bio | Pre-clinical |
| GLP‑1 Peptide Long‑Acting Injectable | Mapi Pharma | Preclinical |
| RZ-858 | Rezubio | Preclinical |